| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | paclitaxel | gCSI | pan-cancer | AAC | 0.072 | 0.2 |
| mRNA | momelotinib | CTRPv2 | pan-cancer | AAC | -0.046 | 0.2 |
| mRNA | trifluoperazine | CTRPv2 | pan-cancer | AAC | 0.051 | 0.2 |
| mRNA | Bortezomib | GDSC1000 | pan-cancer | AAC | 0.067 | 0.2 |
| mRNA | BRD-K90370028 | CTRPv2 | pan-cancer | AAC | -0.072 | 0.2 |
| mRNA | Curcumin | CTRPv2 | pan-cancer | AAC | 0.045 | 0.2 |
| mRNA | BRD-K01737880 | CTRPv2 | pan-cancer | AAC | 0.15 | 0.2 |
| mRNA | narciclasine | CTRPv2 | pan-cancer | AAC | 0.043 | 0.2 |
| mRNA | AT-406 | CTRPv2 | pan-cancer | AAC | 0.061 | 0.2 |
| mRNA | tivozanib | CTRPv2 | pan-cancer | AAC | -0.047 | 0.2 |